369 related articles for article (PubMed ID: 9107078)
21. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
[TBL] [Abstract][Full Text] [Related]
23. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
24. Surface marker abnormalities in myelodysplastic syndromes.
Elghetany MT
Haematologica; 1998 Dec; 83(12):1104-15. PubMed ID: 9949628
[TBL] [Abstract][Full Text] [Related]
25. [Hematological study in 27 patients with myelodysplastic syndrome (MDS)].
Arai T; Taoka T; Yamaoka G; Kiuchi H; Kawanishi K
Rinsho Byori; 1993 Jan; 41(1):107-11. PubMed ID: 8355404
[TBL] [Abstract][Full Text] [Related]
26. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
[TBL] [Abstract][Full Text] [Related]
29. Monocytic leukemia cutis diagnosed simultaneously with refractory anemia with monocytosis: a case report.
Yavorkovsky LL; Zain J; Wu CD; Trivelli L; Cook P
Am J Hematol; 2001 Feb; 66(2):120-2. PubMed ID: 11421290
[TBL] [Abstract][Full Text] [Related]
30. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
31. [Chromosomal structural changes in patients with myelodysplastic syndrome].
Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
[TBL] [Abstract][Full Text] [Related]
32. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
34. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
Malcovati L; Porta MG; Pascutto C; Invernizzi R; Boni M; Travaglino E; Passamonti F; Arcaini L; Maffioli M; Bernasconi P; Lazzarino M; Cazzola M
J Clin Oncol; 2005 Oct; 23(30):7594-603. PubMed ID: 16186598
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
[TBL] [Abstract][Full Text] [Related]
38. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
39. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
[TBL] [Abstract][Full Text] [Related]
40. [Cytogenetic study of 93 myelodysplastic syndromes].
Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
